Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
Q1 2024 Xvivo Perfusion AB Earnings Call Transcript
Interim report January-March 2024
Results from XVIVO's Clinical Trial NIHP2019 for Heart Preservation Presented at ISHLT in Prague
Conference call on Interim Report
Annual Report 2023
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.